CME Sleep
Daytime sleepiness affects 10% of the middle-aged but is often missed because clinicians fail to ask the appropriate questions, thus depriving patients of large potential treatment benefits. A sleep history must be taken as routinely as a cardiac, neurological or other system history.
Background

Obstructive sleep apnoea/hypopnoea syndrome
The obstructive sleep apnoea/hypopnoea syndrome (OSAHS) is much the commonest 'medical' cause of sleepiness (Table 1) , occurring in 1-4% of the middle-aged. OSAHS is the combination of sleepiness or two other major symptoms, such as unrefreshing sleep, difficulty concentrating and nocturnal choking, with five or more apnoeas plus hypopnoeas per hour slept ('apnoea' is defined as a 10-sec pause in breathing, 'hypopnoea' as a 10-sec period during which ventilation is reduced by 50%). OSAHS results from pharyngeal narrowing due to jaw structure or obesity (although only 50% sufferers are obese). It causes a threefold risk of road accidents 1 and raises blood pressure independent of confounders. 2, 3 Narcolepsy Narcolepsy is 100 times less common than OSAHS, occurring in 0.04% of the population. The symptoms of sleepiness and cataplexy (Table 2 ) usually develop in teenage or early adult life. Sleep paralysis, hypnagogic hallucinations and fragmented nocturnal sleep are common but non-specific features. Narcolepsy is associated with decreased hypothalamic production of hypocretin. 4 The association of narcolepsy with HLA DQB1*0602 and the absence of symptoms in childhood suggest that the hypocretin deficiency is acquired, perhaps due to an autoimmune response. 5 
History
Before the initial consultation, sleepy patients and their partners should complete sleep questionnaires (Table 3) . The responses usually allow the physician to start the consultation with a probable diagnosis. The three commonest medical causes of sleepiness can usually be differentiated on history alone (Table 4) . In practice, I define significant sleepiness as an Epworth Sleepiness Scale (ESS) score above 11 (Table 5 ) or recurrent problems with sleepiness whilst driving or actively working.
Investigations
Most sleepy patients require further investigation, the exceptions being those with clearly inadequate sleep duration (<6.5 hours per night) or shift workers, but some of these may require investigation if the sleepiness is troublesome and they have symptoms of OSAHS.
There is considerable dispute about the type of overnight investigation required. The traditional approach was polysomnography (Table 6) , recording up to 30 neurophysiological and respiratory signals overnight, but there is no evidence that this is needed to diagnose OSAHS or narcolepsy. 6, 7 UK waiting times for investigation and treatment of patients with possible OSAHS extend up to five years. 8 This is one reason for using limited sleep studies, with recording of respiratory pattern and oximetry 9 as a quicker, cheaper alternative to polysomnography with similar clinical outcomes. We perform limited studies at home as our diagnostic study, using polysomnography only in those with severe sleepiness and an equivocal home study.
Routine daytime testing of sleepiness is unnecessary in OSAHS. However, in professional drivers and other drivers who remain sleepy on treatment, daytime tests of ability to stay awake, either the Maintenance of Wakefulness Test or Osler Test, 7 have some face-validity; those unable to stay awake during a day of high stakes assessment are unlikely to stay awake driving on motorways 10 -but the converse is not true.
Narcolepsy has neither specific features on overnight recording nor a specific diagnostic test. The most watertight diagnostic criteria are histories of sleepiness and cataplexy associated with a mean In patients with possible narcolepsy without cataplexy, the diagnostic criteria should be more strict. Thus, we perform polysomnography on these patients to exclude OSAHS, followed by an MSLT. Those with normal polysomnography and a mean sleep latency of less than eight minutes with two sleep onsets with REM (SOREM) -and no other reasons for SOREMs such as sleep deprivation, OSAHS or drug withdrawal -can be diagnosed as having 'narcolepsy without cataplexy' .
Management
Management will differ according to cause but all sleepy individuals must be told the risks of driving when sleepy. 10 Around 20% of accidents on major roads are caused by sleeping drivers, the risks being highest at 2-6 am and 2-4 pm. The Driver and Vehicle Licensing Authority (DVLA) has recently produced a useful publication clearly putting the onus on the sleepy driver to be safe and report relevant medical causes. 11 
Insufficient sleep
Sleep restriction causes sleepiness, irritability, depression and impaired concentration. If sleep deprivation is work related, much longer sleep durations at the weekend are common and can be diagnostically helpful. Management is by education about the hazards of sleepiness, combined with encouragement to increase sleep time by an hour or more each night.
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Shift work
Problems are most common in those on rotating shifts. Workers on permanent night shifts who revert to nocturnal sleep patterns on their nights off -as most do -may also have major problems. Older people have greater difficulty adjusting to shifts; 12 those aged over 45 years should be given the option of daytime working when possible. Shift work is associated with an increase in road accidents. Rotating shifts should be designed to have long cycle lengths with at least a week on each shift, and shifts should be progressively delayed when changed, thus moving from morning shift, to late shift, to night. 7 
Obstructive sleep apnoea/hypopnoea syndrome
Weight loss and evening alcohol avoidance should be recommended for those with OSAHS. Continuous positive airway pressure (CPAP) by nasal or face mask is the first-line therapy for OSAHS. There is robust evidence 9 that CPAP improves symptoms, sleepiness, health status, cognition, mood, driving ability and blood pressure in OSAHS. CPAP reduces mean diastolic blood pressure by about 4-5 mmHg in patients with 20 or more 4% desaturations per hour. 2, 3 CPAP is effective but obtrusive, and patients require considerable education and support to adopt CPAP successfully. Over 98% of patients for whom we recommend CPAP start treatment successfully. Long-term use is increased by intensive nurse-led support. 13 Sleepy patients with frequent apnoeas/ hypopnoeas use CPAP well: over 90% of those with more than 30 apnoeas plus hypopnoeas per hour and an ESS score of 11 or higher are using CPAP regularly at three years 14 -comparing well with drug use in other chronic conditions. However, long-term use of CPAP is poorer in patients with 5-15 apnoeas per hour despite short-term benefit from the procedure. 7 Recent advances in CPAP include the development of intelligent devices which deliver varying pressure and may improve outcomes. 15 Patients complying with CPAP who deny sleepiness are usually allowed by the DVLA to drive cars.
Mandibular repositioning splints (MRS), which hold the mandible forward, thus enlarging the upper airway, can improve sleepiness, symptoms and blood pressure in OSAHS. 16 Comparative trials indicate that CPAP remains the treatment of choice with greater efficacy, 17, 18 but MRSs are good second-line therapy. There is little or no role for stimulants in OSAHS and none for uvulopalatopharyngoplasty.
Patients taking sedative or stimulant drugs
Sleepy patients on sedative or stimulant drugs should gradually withdraw them to see whether this helps.
Narcolepsy
Until effective hypocretin analogues become available, therapy will remain based on improving sleep hygiene, encouraging planned daytime naps and drug therapy. The principal drugs used for sleepiness are modafinil and amphetamines.
Modafinil
Modafinil is a non-amphetamine effective in narcolepsy, 19 but there are no data directly comparing modafinil with other drugs. It is expensive and has no anticataplectic effect but, because of proven efficacy, few side effects and low abuse potential, modafinil is the first-choice agent. 20 
Amphetamines
Amphetamines have greater effect on sleepiness, improving sleepiness in over 
Uncommon syndromes
Idiopathic hypersomnia
Idiopathic hypersomnia is a very rare, poorly characterised condition in which patients have prolonged sleep durations, are difficult to waken in the morning and may have automatic behaviour in association with microsleep intrusion into wakefulness. Its diagnosis is one of exclusion, with no positive diagnostic test; it requires evidence of objective daytime sleepiness, preferably on an MSLT where the absence of sleep onset REM is helpful to differentiate from non-cataplectic narcolepsy. Stimulants can help, but modification of lifestyle and sleep habits and planned daytime naps produce little benefit.
Central nervous system hypersomnia
This rare condition can occur following head injuries, cerebrovascular disease and encephalitis. Stimulants can help.
Menstrual-related hypersomnia
Another rare condition for which oral contraceptives may be of benefit is menstrual-related hypersomnia.
The Kleine-Levin syndrome
The rare Kleine-Levin syndrome is characterised by recurrent attacks of sleep, often for more than 20 of the 24 hours for several days. It is associated with bizarre eating and sometimes hypersexuality, 7 starts in teenage life and is more common in males. Stimulants and lithium may also reduce attacks in some, but not all, patients.
Conclusions
Sleepiness is common and dangerous but often overlooked by doctors. Appropriate diagnosis and treatment can greatly improve the quality of life and work performance of affected individuals, road safety for the sufferer and others, and decreased cardiovascular risk in OSAHS.
